News & Events

• December 1, 2013
  

  Patient-Reported Outcomes In Clinical Trials Of CKD-Related Therapies: Report Of A Symposium Sponsored By The National Kidney Foundation And The US Food And Drug Administration

• October 29, 2013
  

  Evolving Global Regulatory Science Through the Voluntary Submission of Data: A 2013 Assessment

  Walker EG, Brumfield M, Compton C, Woosley R. Evolving Global Regulatory Science Through the Voluntary Submission of Data A 2013 Assessment. Therapeutic Innovation & Regulatory Science. 2013 Oct 29.

   

• August 1, 2013
  

  Understanding Placebo Responses In Alzheimer’s Disease Clinical Trials From The Literature Meta-data And CAMD Database

• June 1, 2013
  

  Drug-Resistant Tuberculosis: Time for Visionary Political Leadership

  Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A. Drug-Resistant Tuberculosis: Time for Visionary Political Leadership. The Lancet Infectious Diseases. 2013 Jun;13(6):529–39.

• June 1, 2013
  

  ePRO Systems Validation: Clearly Defining The Roles Of Clinical Trial Teams And ePRO System Providers